<p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Par19">Despite these limitations, this study provides insights into the relationship between vaccination against COVID-19 and outcomes in COVID-19-associated AIS cases. Future work should focus on better understanding the head-to-head comparison of Pfizer vs. Moderna or other vaccinations, as well as better understanding the mechanism through which COVID-19 vaccination reduces the risk of severe AIS sequelae in the setting of COVID-19.</p>